Blog Archives - Page 22 of 32 - Банка за матични клетки

Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19.

As the pandemic continues, the race is truly on to find an effective treatment for COVID-19. With more than 500 clinical trials currently underway across the world, researchers are channelling all of their efforts and expertise in the hope of finding a cure.

September is Muscular Dystrophy Month and as part the effort to raise awareness of this condition, we will be discussing what muscular dystrophy is, how it affects our bodies, and how cord blood stem cells could help sufferers.

A small study using umbilical cord blood stem cells to treat COVID-19 suggests that these stem cells could significantly improve survival rates and accelerate recovery time for critically ill COVID-19 patients. The study recently published in Stem Cells Translational Medicine included 24 patients hospitalised in the US suffering the most severe form of COVID-19.

Researchers have discovered that infusing umbilical cord blood has safely and effectively treated 44 children born with various non-cancerous genetic diseases, including sickle cell disease, Thalassemia, Hunter syndrome and Krabbe disease. The study is the largest trial of its kind to date.

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

As we come to the end of another great Cord Blood Awareness Month, we will be taking a look at just why cord blood banking is so important and what our options are for saving cord blood. Whilst the profile of cord blood banking has increased in recent years, many misconceptions and myths still exist and many people are still unaware of the importance of umbilical cord blood. Here are some key facts:

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will be crucial to achieving this objective.

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

Stem Cell Blog

Stem Cell Therapy: Clinical Trial Reveals Promise for COVID-19 Treatment

Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19.

As the pandemic continues, the race is truly on to find an effective treatment for COVID-19. With more than 500 clinical trials currently underway across the world, researchers are channelling all of their efforts and expertise in the hope of finding a cure.

Muscular Dystrophy Awareness Month

September is Muscular Dystrophy Month and as part the effort to raise awareness of this condition, we will be discussing what muscular dystrophy is, how it affects our bodies, and how cord blood stem cells could help sufferers.

Boosting COVID-19 Survival with Umbilical Cord Stem Cells

Umbilical cord blood successfully treats rare genetic diseases

Researchers have discovered that infusing umbilical cord blood has safely and effectively treated 44 children born with various non-cancerous genetic diseases, including sickle cell disease, Thalassemia, Hunter syndrome and Krabbe disease. The study is the largest trial of its kind to date.

5 ground-breaking clinical trials using cord blood

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

Cord Blood Awareness Month Webinar with Cells4Life

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

Cord Blood Awareness Month: bin it or bank it?

Second HIV patient cured with stem cell treatment

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

Adding 5 Healthy Years: Is It Possible in Our Ageing Population?

A Cure for HIV? New Cord Blood Cancer Trial Announced

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

Could Mitochondria Transplantation Roll Back Ageing?

Reprogrammed Stem Cells Could Bring About Long-Term Cancer Remission

Stem Cell Therapy for Hearing Loss to Begin First In-Human Trial

Could Stem Cells Help Treat Acute-on-Chronic Liver Failure?

Wharton’s Jelly Stem Cells Show Promise for Chronic Spinal Cord Injury in New Study

Cells4Life Blog Posts

Could Mitochondria Transplantation Roll Back Ageing?

Reprogrammed Stem Cells Could Bring About Long-Term Cancer Remission

Stem Cell Therapy for Hearing Loss to Begin First In-Human Trial

Could Stem Cells Help Treat Acute-on-Chronic Liver Failure?

Wharton’s Jelly Stem Cells Show Promise for Chronic Spinal Cord Injury in New Study

Stem Cell Blog

Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19.

As the pandemic continues, the race is truly on to find an effective treatment for COVID-19. With more than 500 clinical trials currently underway across the world, researchers are channelling all of their efforts and expertise in the hope of finding a cure.

September is Muscular Dystrophy Month and as part the effort to raise awareness of this condition, we will be discussing what muscular dystrophy is, how it affects our bodies, and how cord blood stem cells could help sufferers.

Researchers have discovered that infusing umbilical cord blood has safely and effectively treated 44 children born with various non-cancerous genetic diseases, including sickle cell disease, Thalassemia, Hunter syndrome and Krabbe disease. The study is the largest trial of its kind to date.

As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades.

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar:

In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.

Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.

Cord blood stem cells could cure blood cancer and HIV at the same time, thanks to a new clinical trial run by the Fred Hutchinson Cancer Research Centre in Seattle, Washington.

Scientists at ‘Hutch’ announced their newest project last week, which will see 10 HIV-positive patients with blood cancer undergo cord blood transplantation.

Cells4Life Blog Posts

To wrap up Cord Blood Awareness Month, Cells4Life are hosting a webinar on Friday 31^st July at 1pm. We’ll be discussing all things umbilical cord blood and why it is so important. Here’s everything you need to know for the webinar: